A new clinical trial is investigating whether removing clots using a modified access point can better prevent post-thrombotic syndrome in patients with extensive deep vein thrombosis.
A new review of 12 studies found gut microbiome changes in patients with immune thrombocytopenia, though results were inconsistent across populations and methods.